RU2020108198A3 - - Google Patents

Download PDF

Info

Publication number
RU2020108198A3
RU2020108198A3 RU2020108198A RU2020108198A RU2020108198A3 RU 2020108198 A3 RU2020108198 A3 RU 2020108198A3 RU 2020108198 A RU2020108198 A RU 2020108198A RU 2020108198 A RU2020108198 A RU 2020108198A RU 2020108198 A3 RU2020108198 A3 RU 2020108198A3
Authority
RU
Russia
Application number
RU2020108198A
Other languages
Russian (ru)
Other versions
RU2020108198A (ru
RU2787595C2 (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2020108198A publication Critical patent/RU2020108198A/ru
Publication of RU2020108198A3 publication Critical patent/RU2020108198A3/ru
Application granted granted Critical
Publication of RU2787595C2 publication Critical patent/RU2787595C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591Stabilisation, fragmentation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52Constant or Fc region; Isotype
    • C07K2317/526CH3 domain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565Complementarity determining region [CDR]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/90Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/94Stability, e.g. half-life, pH, temperature or enzyme-resistance
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
RU2020108198A 2017-07-27 2018-07-27 Высококонцентрированные составы антител к c5 RU2787595C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762537741P 2017-07-27 2017-07-27
US62/537,741 2017-07-27
PCT/US2018/044071 WO2019023564A1 (en) 2017-07-27 2018-07-27 ANTI-C5 ANTIBODY FORMULATIONS WITH HIGH CONCENTRATION

Related Child Applications (1)

Application Number Title Priority Date Filing Date
RU2022134519A Division RU2022134519A (ru) 2017-07-27 2018-07-27 Высококонцентрированные составы антител к c5

Publications (3)

Publication Number Publication Date
RU2020108198A RU2020108198A (ru) 2021-08-27
RU2020108198A3 true RU2020108198A3 (zh) 2022-02-04
RU2787595C2 RU2787595C2 (ru) 2023-01-11

Family

ID=

Also Published As

Publication number Publication date
SI3658184T1 (sl) 2024-01-31
MX2020001052A (es) 2022-05-18
US11365241B2 (en) 2022-06-21
DK3658184T3 (da) 2023-11-27
WO2019023564A8 (en) 2019-12-26
BR112020001703B1 (pt) 2024-01-02
US20200369751A1 (en) 2020-11-26
FI3658184T3 (fi) 2023-11-30
JP7277649B2 (ja) 2023-05-19
CN116271012A (zh) 2023-06-23
EP3658184B1 (en) 2023-09-06
CN111315411A (zh) 2020-06-19
US20230106734A1 (en) 2023-04-06
JP2022105625A (ja) 2022-07-14
PT3658184T (pt) 2023-11-29
PL3658184T3 (pl) 2024-02-26
RU2020108198A (ru) 2021-08-27
KR20230066126A (ko) 2023-05-12
JP7079844B2 (ja) 2022-06-02
KR20200034739A (ko) 2020-03-31
EP4218813A2 (en) 2023-08-02
EP3658184A1 (en) 2020-06-03
CO2020001960A2 (es) 2020-04-13
AU2018306612A1 (en) 2020-01-16
EP4218813A3 (en) 2023-08-16
US20230257456A1 (en) 2023-08-17
LT3658184T (lt) 2023-11-27
BR112020001703A2 (pt) 2020-07-21
MX2022005990A (es) 2022-06-17
AU2018306612C1 (en) 2023-11-09
CN111315411B (zh) 2023-02-28
CA3069756A1 (en) 2019-01-31
JP2020528894A (ja) 2020-10-01
AU2018306612B2 (en) 2022-09-01
HUE064436T2 (hu) 2024-03-28
US12012448B2 (en) 2024-06-18
AU2022279414A1 (en) 2023-03-02
WO2019023564A1 (en) 2019-01-31
KR102576012B1 (ko) 2023-09-07
JP2023090876A (ja) 2023-06-29
ES2965486T3 (es) 2024-04-15

Similar Documents

Publication Publication Date Title
RU2020108198A3 (zh)
BR202018014992U2 (zh)
BR202017025154U2 (zh)
BR202017021228U2 (zh)
BR202017020981U2 (zh)
BE2017C035I2 (zh)
BR202017017068U2 (zh)
BR202017016984U2 (zh)
BR202017016924U2 (zh)
BR102017015250A2 (zh)
BR102017014430A2 (zh)
BR202017012548U2 (zh)
BR202017011220U2 (zh)
BR202017010814U2 (zh)
BR202017010373U2 (zh)
BR202017009870U2 (zh)
BR202017006953U2 (zh)
BR202017004898U2 (zh)
BR102017003115A2 (zh)
BR202017002937U2 (zh)
CN304012889S (zh)
CN303991390S (zh)
CN303991336S (zh)
CN303991096S (zh)
CN303990998S (zh)